These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
557 related items for PubMed ID: 19443079
21. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Vila-Farres X, Garcia de la Maria C, López-Rojas R, Pachón J, Giralt E, Vila J. Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084 [Abstract] [Full Text] [Related]
22. Investigation of biofilm formation in Acinetobacter baumannii isolates and their colistin susceptibilities in biofilm. Milletli Sezgin F, Coban AY, Gunaydin M. Int J Antimicrob Agents; 2013 Feb; 41(2):199. PubMed ID: 23182537 [No Abstract] [Full Text] [Related]
23. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Shields RK, Kwak EJ, Potoski BA, Doi Y, Adams-Haduch JM, Silviera FP, Toyoda Y, Pilewski JM, Crespo M, Pasculle AW, Clancy CJ, Nguyen MH. Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436 [Abstract] [Full Text] [Related]
33. Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples. Kim HA, Ryu SY, Seo I, Suh SI, Suh MH, Baek WK. Microb Drug Resist; 2015 Aug; 21(4):452-7. PubMed ID: 25714496 [Abstract] [Full Text] [Related]
34. Inhibition of Acinetobacter baumannii, Staphylococcus aureus and Pseudomonas aeruginosa biofilm formation with a class of TAGE-triazole conjugates. Huigens RW, Rogers SA, Steinhauer AT, Melander C. Org Biomol Chem; 2009 Feb 21; 7(4):794-802. PubMed ID: 19194596 [Abstract] [Full Text] [Related]
35. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii. Plachouras D, Giamarellos-Bourboulis EJ, Kentepozidis N, Baziaka F, Karagianni V, Giamarellou H. Diagn Microbiol Infect Dis; 2007 Apr 21; 57(4):419-22. PubMed ID: 17188449 [Abstract] [Full Text] [Related]
36. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Song JY, Lee J, Heo JY, Noh JY, Kim WJ, Cheong HJ, Hwang IS. Int J Antimicrob Agents; 2008 Sep 21; 32(3):281-4. PubMed ID: 18650070 [No Abstract] [Full Text] [Related]
37. Superior activity of colistin against Pseudomonas aeruginosa clinical isolates, including multidrug-resistant isolates, from multiple infection sources from 2007 to 2009. Hawser SP. Int J Antimicrob Agents; 2011 Jun 21; 37(6):587. PubMed ID: 21493045 [No Abstract] [Full Text] [Related]
38. Metallo beta lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii. John S, Balagurunathan R. Indian J Med Microbiol; 2011 Jun 21; 29(3):302-4. PubMed ID: 21860115 [Abstract] [Full Text] [Related]